1017 EFFICACY OF TENOFOVIR DF TREATMENT IN PATIENTS WITH A SUBOPTIMAL RESPONSE TO ADEFOVIR DIPIVOXIL

1016 LOW RATES OF NUCLEOS(T)IDE-ASSOCIATED ADVERSE EVENTS IN THE LONG-TERM EXPERIENCE WITH ENTECAVIR M. Manns, U.S. Akarca, T.-T. Chang, W. Sievert, S.-K. Yoon, N. Tsai, A. Min, A. Pangerl, S. Beebe, M. Yu, S. Wongcharatrawee. Department of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germany; Department of Gastroenterology, Ege University, Faculty of Medicine, Izmir, Turkey; National Cheng Kung University Medical College, Tainan, Taiwan R.O.C.; Department of Medicine, Monash University, Monash Medical Centre, Melbourne, VIC, Australia; Kangnam St. Mary Hospital, The Catholic University of Korea, Seoul, Republic of Korea; John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, Beth Israel Medical Center, New York, NY, USA; Research and Development, Bristol-Myers Squibb Company, Munich, Germany; Research and Development, Bristol-Myers Squibb Company, Wallingford, CT, USA E-mail: manns.michael@mh-hannover.de